UBS raised the target price for ASMPT (00522) to HKD135 from HKD95 and maintained the "buy" rating.
The research house said it edges up 2026/27E earnings 3%/4% to reflect better visibility on TCB growth.
【你點睇?】屯門開槍案,據報疑犯患精神病並在此前缺席覆診。你認為政府目前對社區精神健康的支援是否足夠?若有「甩底」個案應如何處理?► 立即投票

























